Live from the NIH registry
Studies recruiting near Ann Arbor right now
Top 25 of 1,186 recruiting studies, sorted by proximity — each links to its official registry page
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
B Acute Lymphoblastic Leukemia
Phase 2
Interventional 222 participants sought
C S Mott Children's Hospital — Ann Arbor, Michigan (0.5 mi)
· Sponsor: National Cancer Institute (NCI)
A Study to Evaluate Safety and Efficacy of Bomedemstat (MK-3543-017)
Thrombocythemia, Essential, Primary Myelofibrosis
Phase 3
Interventional 400 participants sought
University of Michigan ( Site 6000) — Ann Arbor, Michigan (0.5 mi)
· Sponsor: Merck Sharp & Dohme LLC
A Study of Cemiplimab Plus Chemotherapy Versus Cemiplimab Plus Chemotherapy Plus Other Cancer Treatments for Adult Patients With Operable Non-Small Cell Lung Cancer (NSCLC)
Non-Small Cell Lung Cancer
Phase 2
Interventional 120 participants sought
Detroit Clinical Research Center — Farmington Hills, Michigan (23.1 mi)
· Sponsor: Regeneron Pharmaceuticals
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
PIK3CA Mutation, HER2- Negative Breast Cancer
Phase 3
Interventional 540 participants sought
University of Michigan — Ann Arbor, Michigan (0.5 mi)
· Sponsor: Relay Therapeutics, Inc.
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Previously Treated Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 10,000 participants sought
Trinity Health Saint Joseph Mercy Hospital Ann Arbor — Ann Arbor, Michigan (0.5 mi)
· Sponsor: SWOG Cancer Research Network
Treatment of Moderate to Severe Refractory Crohn's Disease
Crohns Disease
Phase 1, Phase 2
Interventional 39 participants sought
University of Michigan — Ann Arbor, Michigan (0.5 mi)
· Sponsor: Tr1X, Inc.
A Study to Investigate Efficacy and Safety of SAR441566 in Patients With Ulcerative Colitis
Colitis Ulcerative
Phase 2
Interventional 204 participants sought
University of Michigan Health System - Ann Arbor- Site Number : 8400010 — Ann Arbor, Michigan (0.5 mi)
· Sponsor: Sanofi
DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer
Endometrial Cancer
Phase 3
Interventional 600 participants sought
Research Site — Ann Arbor, Michigan (0.5 mi)
· Sponsor: AstraZeneca
Treatment of the Biceps With Concomitant Supraspinatus Tears
Supraspinatus Tear
N/A
Interventional 180 participants sought
Sports Medicine and Shoulder Surgery, University of Michigan — Ann Arbor, Michigan (0.5 mi)
· Sponsor: La Tour Hospital
Study Evaluating the Safety and Efficacy of Neffy or Intramuscular Adrenalin in Patients With Allergic Reactions After Oral Food Challenge or Allergen Immunotherapy
Allergic Reactions
Phase 4
Interventional 600 participants sought
University Of Michigan — Ann Arbor, Michigan (0.5 mi)
· Sponsor: ARS Pharmaceuticals, Inc.
Access Sheath and Stent Trial
Kidney Stone, Ureteral Stone
N/A
Interventional 184 participants sought
University of Michigan — Ann Arbor, Michigan (0.5 mi)
· Sponsor: University of Michigan
Evaluating Screening Adherence Between Moment for Parents App and Attention Control
Mental Health Screening Adherence
N/A
Interventional 160 participants sought
Remote/Virtual Participation — Ann Arbor, Michigan (0.5 mi)
· Sponsor: Poisera, Inc.
A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)
Ulcerative Colitis
Phase 4
Interventional 65 participants sought
Huron Gastroenterology Associates, P.C. — Ypsilanti, Michigan (6.5 mi)
· Sponsor: Takeda
Move and Snooze: Adding Insomnia Treatment to an Exercise Program to Improve Pain Outcomes in Older Adults With Knee Osteoarthritis
Knee Osteoarthritis, Insomnia
N/A
Interventional 288 participants sought
University of Michigan — Ann Arbor, Michigan (0.5 mi)
· Sponsor: University of Michigan
ACT001 for the Treatment of Diffuse Intrinsic Pontine Gliomas and H3K27-altered High Grade Gliomas
Diffuse Intrinsic Pontine Gliomas (DIPG), Progressive DIPG
Phase 2
Interventional 60 participants sought
C.S. Mott Children's Hospital — Ann Arbor, Michigan (0.5 mi)
· Sponsor: Nationwide Children's Hospital
Phase 3, Open-label, Single-dose Study of CSL222 in Adolescent Male Subjects (≥ 12 to < 18 Years of Age) With Severe or Moderately Severe Hemophilia B
Hemophilia B
Phase 3
Interventional 20 participants sought
University of Michigan Medical Center — Ann Arbor, Michigan (0.5 mi)
· Sponsor: CSL Behring
KIDney Injury in Times of COVID-19 (KIDCOV)
SARS-CoV Infection, Covid19
N/A
Observational 2,000 participants sought
University of Michigan — Ann Arbor, Michigan (0.5 mi)
· Sponsor: University of California, San Francisco
Prediction Augmented Screening Initiative
Lung Cancer, Lung Cancer Screening
N/A
Interventional 23,520 participants sought
VA Ann Arbor Healthcare System, Ann Arbor, MI — Ann Arbor, Michigan (0.5 mi)
· Sponsor: VA Office of Research and Development
A Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease Activity To Prevent Migraine in Participants Aged 12 to 17 Years
Chronic Migraine
Phase 3
Interventional 420 participants sought
Michigan Headache & Neurological Institute /ID# 270942 — Ann Arbor, Michigan (0.5 mi)
· Sponsor: AbbVie
Artificial Intelligence (AI) for Proximal Caries Detection and Its Impact on Treatment Threshold
Caries,Dental
N/A
Interventional 60 participants sought
University of Michigan — Ann Arbor, Michigan (0.5 mi)
· Sponsor: University of Michigan
Multi-Center Clean Air Randomized Controlled Trial in COPD
Chronic Obstructive Pulmonary Disease (COPD)
Phase 3
Interventional 770 participants sought
University of Michigan — Ann Arbor, Michigan (0.5 mi)
· Sponsor: JHSPH Center for Clinical Trials
Implementation pRogram to Improve Screening and Management for CKD in Diabetes (Program 1) (IRIS-CKD)
Chronic Kidney Disease(CKD), Type 2 DM
N/A
Interventional 750 participants sought
University of Michigan — Ann Arbor, Michigan (0.5 mi)
· Sponsor: Duke University
HCMR Re-Imaging Study
Hypertrophic Cardiomyopathy (HCM)
N/A
Observational 314 participants sought
University of Michigan — Ann Arbor, Michigan (0.5 mi)
· Sponsor: Christopher Kramer
A Study Assessing Long-Term Safety and Effectiveness in Treatment Management of Atrial Fibrillation With VARIPULSE Catheter System
Atrial Fibrillation
N/A
Interventional 276 participants sought
Trinity Health — Ypsilanti, Michigan (6.5 mi)
· Sponsor: Biosense Webster, Inc.
RESET System Pivotal Trial (Rev F)
Diabetes type2, Obesity
N/A
Interventional 264 participants sought
Michigan Medicine, Division of Gastroenterology and Hepatology — Ann Arbor, Michigan (0.5 mi)
· Sponsor: Morphic Medical Inc.